ILLUMINA, INC. is 16.7x more valuable than Alamar Biosciences, Inc. by market capitalization ($24.84 B vs $1.49 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALMR | ILMN |
|---|---|---|
| Market cap | $1.49 B | $24.84 B |
| US-listed rank | #2318 | #539 |
| Revenue (latest FY) | - | $4.34B |
| Net income (latest FY) | - | $850.00M |
| Net margin | - | 19.6% |
| P/E (trailing FY) | - | 29.2 |
| SEC filings | 38 | 3,713 |
ILLUMINA, INC. is 16.7x more valuable than Alamar Biosciences, Inc. by market capitalization ($24.84 B vs $1.49 B).
Full pages: Alamar Biosciences, Inc. and ILLUMINA, INC., or browse the full rankings.